Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07196436 · ClinicalTrials.gov registry record · NA

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

A NA study of Stress and Quality of Life, sponsored by The University of Texas at Arlington.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT07196436: Recruiting NA study of Stress and Quality of Life, sponsored by The University of Texas at Arlington.

NCT07196436 is a NA study of Stress and Quality of Life that is actively recruiting participants, run by The University of Texas at Arlington. The registered enrollment target is 80 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07196436, a NA study of Stress and Quality of Life, is actively recruiting participants, sponsored by The University of Texas at Arlington.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adults with asthma in low-income households in the Dallas-Fort Worth (DFW) metropolitan area, TX. Secondary goals include: (1) examining associations among asthma outcomes, exposure to indoor air pollutants and mold, and housing-related factors, (2) conducting a cost-benefit analysis of ERV and PAC interventions for improving IAQ, mold control, and health outcomes, and (3) evaluating the utility of cost-effective methods and protocols for measuring IAQ and mold for indoor air pollution epidemiology studies and for providing practical information to patients and their physicians. Using a double-blind, placebo-controlled randomized controlled trial, 80 households will be assigned to receive active or placebo versions of ERVs or PACs. Environmental exposures and housing conditions will be monitored alongside comprehensive health assessments, including lung function tests and validated surveys on asthma control, quality of life, stress, and sleep quality.

Primary Outcome

Pulmonary function will be assessed using an EasyOne Air spirometer. The primary parameters measured include Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and the FEV₁/FVC ratio.

Interventions

  • DEVICE Energy Recovery Ventilator
  • DEVICE Portable Air Cleaner
  • DEVICE Energy Recovery Ventilator (Sham)
  • DEVICE Portable Air Cleaner (Sham)

Study Locations (2)

Texas

  • University of Texas at Arlington - Arlington
  • Rebuilding Together North Texas - Plano

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-10-10
Est. Completion 2028-02-28
Phase NA

What NCT07196436 shows while recruiting

NCT07196436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (90% lower).

The record links to 5 conditions, with Stress appearing as the primary indexed condition, and to 4 interventions - of which Energy Recovery Ventilator is the first listed.

NCT07196436 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07196436 about?

NCT07196436 is a clinical study titled "Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study". The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adu...

What is the current status of trial NCT07196436?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-10-10. Estimated completion is 2028-02-28.

What conditions does trial NCT07196436 study?

This clinical trial studies the following conditions: Stress, Quality of Life, Sleep Quality, Pulmonary Function, Asthma Control.

What interventions are being tested in trial NCT07196436?

The interventions under investigation include: Energy Recovery Ventilator (DEVICE), Portable Air Cleaner (DEVICE), Energy Recovery Ventilator (Sham) (DEVICE), Portable Air Cleaner (Sham) (DEVICE).

Who is sponsoring clinical trial NCT07196436?

This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07196436 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07196436's enrollment target sits among peer trials

80 75th of 152 higher than 76 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07196436, the US trial registry maintained by the National Library of Medicine. NCT07196436 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.